Search for: "Bayer AG" Results 461 - 480 of 641
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Apr 2010, 3:38 pm by Dr. Shezad Malik
One study, which looked at blood clot risks in healthy Danish women ages 15 to 49, found that of 4,213 cases of various kinds of blood clots reported between 1995 and 2005, more than 2,000 occurred in women who used oral contraceptives. [read post]
22 Apr 2010, 3:51 am
Teva (Orange Book Blog) (FDA Law Blog) Levistra (Vardenafil) – US: District Court Delaware: Patent infringement complaint following ANDA filing: Bayer Schering Pharma AG et al v Teva Pharmaceuticals USA, Inc et al (Patent Docs) Nexavar (Sorafenib) – India: Bayer sues Cipla for infringement of Nexavar patent before Delhi High Court (Spicy IP) Norfloxacin – Canada: Federal Court: Judgment in s 8 proceeding: Apotex v Merck (Pharmacapsules) Prandin… [read post]
17 Apr 2010, 4:32 am by Dr. Shezad Malik
One study looked at blood clot rates in Danish women ages 15 to 49 with no history of cardiovascular disease. [read post]
15 Apr 2010, 4:02 pm by Victoria VanBuren
This course will provide discussions on the following topics: • The Practice of Law in the Information Age: How to Survive and Flourish • Authenticating Tweets • The Deposition of Corporate Representatives • Parallel Criminal and Civil Cases • Discovery Issues in Arbitration Karl Bayer will be presenting the section on Arbitration on May 21st. [read post]
2 Apr 2010, 9:13 pm by Ed Wallis
Bayer AG, Germany’s largest drugmaker, was accused in a lawsuit of ignoring health risks of the contraceptive Yaz and advertising the drug as safe to boost sales. [read post]
25 Mar 2010, 7:49 am by Dr. Shezad Malik
Bayer AG, Germany’s largest drugmaker, was accused in a lawsuit of ignoring health risks of the contraceptive Yaz and advertising the drug as safe to boost sales. [read post]
11 Mar 2010, 5:47 am by Greenberg & Bederman
15 cigarettes per day) and over age 35 ·         Hypersensitivity to any component of this product This is all well and good, but that doesn’t explain the hundreds of women who are suffering from none of these symptoms who are still being injured and hospitalized. [read post]
5 Mar 2010, 1:30 am by John J. Cord
Genetech Inc. and Bayer AG paid for experimental medications for Mr. [read post]
21 Feb 2010, 8:25 pm by Patent Docs
Bayer Schering Pharma AG et al. v. [read post]
17 Feb 2010, 8:00 am by Karen E. Keller
Bayer Healthcare LLC (patent infringement) 1/5: Cephalon Inc. and Cephalon France v. [read post]
15 Feb 2010, 10:49 am by Jason Krebs
 That translates to a lot of money going to Bayer AG and a lot of incentive for them to keep Yaz as a viable drug through marketing and/or misleading claims. [read post]
12 Feb 2010, 6:55 am by Ashby Jones
In the latest example, Bayer AG failed this week to persuade the Delhi High Court to direct India’s chief drug regulator to not give marketing approval to a competitor’s copy of its cancer medicine Nexavar. [read post]
12 Feb 2010, 1:30 am by John J. Cord
14 years of age who have no known contraindications to oral contraceptive therapy, desire contraception, and have achieved menarcheIs this simply a function of Bayer knowing what they can get away with? [read post]
11 Feb 2010, 4:14 am
Bayerische Hypo-Und Vereins Bank AG-New York Branch Subscription Required U.S. [read post]
10 Feb 2010, 4:47 pm
– Crofelemer treatment for dehydration (Spicy IP) India: Nay patent linkages: Bayer v UOI upheld by Division Bench of Delhi High Court (Spicy IP) (Generic Pharmaceuticals and IP) India: Rejections from pre-grant appealable to IPAB by patent applicant: UCB Farchim SA v Cipla & Ors (Generic Pharmaceuticals and IP) (The Vanishing Point) (Indian Patent Oppositions) (Spicy IP) (Spicy IP) India: Buckuchurbu and (re) hydrating indian traditional knowledge (Spicy IP) Peru: Maize as… [read post]
6 Feb 2010, 10:14 am by Lawrence B. Ebert
Kazuhiro Sakurada, former Head of Global Drug Discovery Regenerative Medicine Bayer Schering Pharma AG. [read post]
7 Jan 2010, 9:19 pm by Veronika Gaertner
Bayer CropScience AG) There is a new reference for a preliminary ruling on the interpretation of the term "civil and commercial matters" which has been referred to the ECJ by the Supreme Court of the Netherlands (Hoge Raad der Nederlanden) asking inter alia the following question: Is the phrase 'civil and commercial matters' in Article 1 of Regulation (EC) No 44/2001 on jurisdiction and the recognition and enforcement of judgments in civil and commercial matters… [read post]